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Abstract 
Background 
Respiratory syncytial virus (RSV) is the predominant viral cause of childhood pneumonia. Little is 
known about the role of viral-coinfections in the clinical severity in children infected with RSV. 
Methods 
We conducted a systematic literature review of publications comparing the clinical severity between 
RSV mono-infection and RSV co-infection with other viruses in children under five years (<5y). 
Clinical severity was measured using the following six clinical outcomes: hospitalisation, length of 
hospital stay, use of supplemental oxygen, intensive care unit (ICU) admission, mechanical 
ventilation and deaths. We summarised the findings by clinical outcome and conducted random-
effect meta-analyses, where applicable, to quantitatively synthesize the association between RSV 
mono-infection/RSV co-infection and the clinical severity. 
Results 
Overall, no differences in the clinical severity were found between RSV mono-infection and RSV co-
infection with any viruses, except for the RSV-human metapneumovirus (hMPV) co-infection. RSV-
hMPV coinfection was found to be associated with a higher risk of ICU admission (odds ratio [OR]: 
7.2, 95% confidence interval [CI]: 2.1–25.1; OR after removal of the most influential study: 3.7, 95% 
CI: 1.1–12.3). We also observed a trend from three studies that RSV-hMPV coinfections were likely 




Our findings suggest that RSV-hMPV coinfections might be associated with increased risk for ICU 
admission in children <5y compared with RSV mono-infection but such association does not imply 
causation. Our findings do not support the association between RSV coinfections with other viruses 
and clinical severity but further large-scale investigations are needed to confirm the findings. 
Registration 




Respiratory syncytial virus (RSV) is the predominant viral cause of childhood pneumonia [1-3]. It is 
estimated that in the year of 2015, there were 33.1 million episodes of RSV-associated acute lower 
respiratory infections (ALRI) and 3.2 million RSV-ALRI hospital admissions in children under five years 
of age (<5y) globally [4]. RSV activity is found to be seasonal in most locales globally and associated 
with low temperature and/or high relative humidity [5]. Individual-level risk factors for RSV-ALRI 
include prematurity, low birth weight, being male, having siblings, maternal smoking, history of 
atopy, no breastfeeding and crowding [6].  
As new diagnostic techniques for respiratory pathogens became more widely available in research 
and clinical settings, co-detection of RSV with another respiratory virus is not uncommon. Studies 
have shown that co-detection of RSV with other respiratory viruses could account for 35–40% of all 
RSV infections in young children [7-9]. However, the role of viral-coinfections remains unclear in the 
severity of RSV-associated respiratory diseases. Several systematic reviews suggest that there is no 
association between disease severity and viral co-infections (compared to mono-infections) but little 
was reported in these reviews regarding RSV-specific effects [10-13]. Therefore, we conducted a 
systematic review and meta-analysis to understand the role of viral-coinfections with RSV in the 
clinical severity in children <5y. 
Methods 
Literature search 
This systematic review was conducted and reported according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines (checklist attached in the appendix pp 
1–2) [14]. The protocol of this review was registered in International Prospective Register of 
Systematic Review (PROSEPRO) with registration number CRD42019154761. We searched three 
databases, searched Medline (Ovid), Embase (Ovid) and Global Health (Ovid) for publications by 31st 
December 2019 (with no limits on the start year) that reported morbidity and mortality by RSV-
specific mono-infection and co-infection in children <5y. Additional references from citation 
searching were also considered for inclusion.  
We considered the following outcomes a priori in our review: being hospitalised, length of hospital 
stay, use of supplemental oxygen, intensive care unit (ICU) admission, mechanical ventilation and 
deaths. The search strategy (appendix pp 3–5) is featured by the combination of terms including 
RSV, coinfection/mixed infection/superinfection, and the outcomes as stated above. We did not 
include age-specific search terms in the search strategy as studies including a wider age group (i.e. 
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all ages) could still have reported sub-age-groups that are eligible to be included in our review. No 
restrictions were applied to the language of the publications.    
Selection criteria 
Inclusion criteria 
 Population-based studies reporting any laboratory-confirmed viral respiratory coinfection 
with RSV and mono respiratory infection of RSV in children <5y or any sub-age-groups; AND 
 At least one of the following outcomes should be reported separately in coinfection group 
and mono-infection group: being hospitalised, length of hospital stay, use of supplemental 
oxygen, ICU admission, mechanical ventilation and deaths. 
Exclusion criteria 
 Studies that only reported nosocomial infections; OR 
 Studies that only included children with comorbidities or preterm children; OR 
 Studies that reported few than 10 cases; OR 
 Reviews or studies reporting data that were previously reported by another study 
Literature selection and extraction 
Based on the selection criteria above, two reviewers (YL and PP) independently screened titles, 
abstracts and full-texts of the retrieved records from the literature search. For data extraction, a 
questionnaire was tailored to collect relevant information and results from included studies. The 
questionnaire consists of two forms, data cataloguing and data extraction. Data cataloguing form 
collects general information of the study design, study subjects, diagnostic test and statistical 
method. Data extraction form collects results of comparisons in the outcomes between mono-
infection group and coinfection group. More details on the data cataloguing and extraction forms 
are available in the appendix (p6). Two reviewers (PP and FM) independently conducted the data 
extraction. Any inconsistencies were resolved among YL, PP and FM.  
Quality assessment 
Quality assessment was conducted for all included studies independently by two reviewers (PP and 
FM). The questionnaire used for the quality assessment was modified based on the Critical Appraisal 
Skills Programme (CASP) checklist for cohort studies. The questionnaire contained the following 
seven questions: 1. Did the study address a clearly focused issue? 2. Were the subjects recruited in 
an acceptable way? 3. Was the exposure accurately measured to minimise bias? 4. Was the outcome 
accurately measured to minimise bias? 5. Have the authors taken account of any confounding 
factors in the design and/or analysis? 6. Can the results be applied to the local population? 7. Do the 
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results of this study fit with other available evidence? Answer to each of the question could be 
“Yes”, “No”, or “Can’t tell”. 
Data analysis 
For each outcome, a narrative summary of results was conducted comparing mono-infection group 
and co-infection group. The summary was further stratified by pathogen pair if two or more studies 
were available for a specific pathogen pair. For the outcome length of hospital stay, no meta-analysis 
was conducted due to the reporting variability (e.g. median and range, median and interquartile 
range, mean and standard deviation, etc.). For outcomes other than length of hospital stay, crude 
odds ratios (OR) were either extracted or calculated from the original results; a random-effect meta-
analysis of ORs was conducted if three or more studies were available per co-infected virus and 
outcome. The choice of conducting a random-effect meta-analysis (rather than fixed-effect meta-
analysis) was based on the anticipation that populations included in the studies differed by ethnicity, 
age, clinical diagnosis and hospital setting (e.g. outpatient, emergency room, inpatient, etc.). Ad-hoc 
sensitivity analysis was conducted for statistically significant meta-analysis results by taking out one 
study each time from the analysis (i.e. the leave-one-out method). Publication bias was assessed by 
visual inspection of the funnel plot and was tested by Egger’s regression method [15]. All statistical 
analyses were conducted using the R software (version 3.5.2) 
Results 
After removal of duplicates, we screened 1720 studies by title and abstract and screened 235 studies 
by full-text for eligibility. The percentage of agreement between the two reviewers during the full-
text screening stage was 93% (218/235). A total of 27 studies [7,8,16-40] were included in our review 
(Figure 1). General information and quality assessment of the included studies is available in the 
appendix (pp 7–9). No studies were excluded based on the quality assessment. PCR was used to 
detect RSV and other viruses in all of the 27 studies. Heterogeneity was observed among populations 
in the studies in terms of country, age group, clinical diagnosis, and setting (e.g. outpatient, 
inpatient, etc.). Eight studies [8,22,26-29,31,37] used statistical models to account for common 
confounders such as age, sex, prematurity and comorbidity. Among studies reporting both 
unadjusted and adjusted results, no substantial differences were observed between the unadjusted 
and adjusted results (Table S1) [8,22,29]. 
Hospitalisation 
Three studies [28,30,35] compared the proportion of being hospitalised between RSV mono-
infection and co-infection. Their findings, however, were not consistent with one study supporting 
increased hospitalisation in co-infection group (OR: 2.67, 95% CI: 1.71–4.18) [30], one study 
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supporting decreased hospitalisation (OR: 0.42, 95% CI: 0.30–0.59) [35], and another study 
supporting no difference [28]. (Table S2) 
Length of hospital stay 
Seventeen studies [7,17-23,25-27,31,32,36,37,39,40] reported the length of hospital stay in the 
mono- and co-infection groups. Although these studies reported the results in various statistical 
measures, most of the results were in support for no association between co-infections and length 
of hospital stay. There was a trend that co-infections with human metapnuemovirus (hMPV) were 
likely to be associated with longer hospital stay but not yet statistically significant. (Table 1) 
Use of supplemental oxygen 
Nine studies [18,20,21,23,25,32,37,39,40] reported the use of supplemental oxygen in mono- and 
co-infection groups. According to the meta-analyses results, RSV coinfections with any viruses, with 
rhinovirus, or with hMPV did not seem to be associated with increased use of supplemental oxygen 
compared with RSV mono-infection (Figure 2). No risk of publication bias was identified. Outside the 
meta-analyses, one study [20] reported that RSV coinfections with adenovirus was associated with 
decreased use of supplemental oxygen (OR: 0.44, 95% CI: 0.25–0.77). 
ICU admission 
Twelve studies [8,17,19,21,22,29,32-36,38] compared the proportion of ICU admission between 
mono- and co-infection groups. While RSV coinfections with any viruses or with rhinovirus did not 
seem to be associated with ICU admission, coinfections with hMPV were found to be highly 
associated with increased risk of ICU admission compared to admission to regular wards (pooled OR: 
7.2, 95% CI: 2.1–25.1). (Figure 3) To further validate the findings on hMPV-RSV coinfection, we 
conducted leave-one-out ad-hoc sensitivity analyses and found that the pooled OR remained 
statistically significant even after the removal of the study by Semple et al [34] that appeared to be 
the most important driver of the results (OR: 3.7, 95% CI: 1.1–12.3). No risk of publication bias was 
identified. 
Outside the meta-analysis above, RSV coinfections with adenovirus (two studies [8,33]), with human 
coronavirus-NL63 (one study [33]), and with parainfluenza virus (two studies [8,33]) were found to 
be associated with higher risk for ICU admission. (Table S3) 
Mechanical ventilation 
Nine studies [16,18,19,21,22,24,26,37,40] compared the proportion of mechanical ventilation in 
mono- and co-infection groups. Meta-analyses results suggest that RSV coinfections with any viruses 
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or with rhinovirus was not associated with increased risk of mechanical ventilation. No risk of 
publication bias was identified. 
Deaths 
Four studies [21,27,35,38] reported deaths in mono- and co-infection groups. These studies reported 
very small number of deaths (range: 3–8) and the results were mixed. (Table S4)  
Discussion 
To our knowledge, this is the first systematic review and meta-analysis focusing on the role of viral 
co-infections in the clinical severity among RSV infected young children. Our findings suggest no 
association between viral co-infections with RSV and clinical severity, except for RSV and hMPV co-
infections, in which this specific pair is found to be associated with higher risk of ICU admission. 
Similar to the findings of previous reviews on non-RSV-specific viral-coinfections [10-13], we found 
no differences in the clinical severity between young children with RSV mono-infection and RSV co-
infections with any viruses combined. Nonetheless, different virus pairs could have different types 
and subtypes of interactions [41]; as a result, their effects on clinical severity could differ and were 
masked from non-virus-specific results. To this end, we conducted separate analyses and summary 
by virus pair where applicable. We found that young children with RSV and hMPV coinfection were 
more likely to be admitted to ICU than those with RSV mono-infection in both the main analysis and 
the ad-hoc leave-one-out analysis. We also observed a trend from three studies [20,23,39] that RSV 
and hMPV coinfections were likely to be associated with longer hospital stay. The observed increase 
in clinical severity of RSV-hMPV coinfection was unlikely due to the pathogenic effect of hMPV alone 
as the no statistical significant difference was observed in the clinical severity of RSV mono-infection 
and hMPV mono-infection [21,23,42]. These findings could have important implications for the 
clinical management of children who were tested positive for both viruses. However, there are 
several caveats about the observed association between RSV-hMPV coinfection and clinical severity. 
First of all, the observed association alone does not indicate causation. Second, there is still a lack of 
biological explanation for the pathogenic effect of this specific virus pair. Third, increased clinical 
severity in RSV-hMPV coinfection was not observed for all of the outcomes in our review. For 
example, RSV-hMPV coinfection was not found to be associated with increased use of supplement 
oxygen; this could be due to either lack of power (i.e. false negative) or no association. 
We found that common confounders of the respiratory virus and disease association, such as age, 
sex, prematurity and comorbidity, did not seem to substantially affect the findings of the association 
between RSV-coinfections and the clinical severity [8,22,29]. Nonetheless, confounding effect was 
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observed in these studies with a more than 10% of change in the estimates, with two studies [22,29] 
showing positive confounding and one showing negative confounding [8]. In addition to the 
aforementioned confounders, bacterial co-infection could also confound the observed effect but this 
was not reported in any of the included studies [43]. For example, pneumococcal infection was 
found to be associated with RSV infection and with increased clinical severity [44,45].  
Our study is not without limitations. First, although our results did not support the association 
between other virus pairs with RSV and clinical severity in young children, we lacked the power to 
reach a firm conclusion of no association. The numbers of RSV-coinfections in most studies were less 
than 50. More large-scale studies are warranted to confirm our findings. Second, we were unable to 
differentiate co-detection from co-infection. Co-detection of RSV with the other virus does not 
necessarily implicate pathogenic effect of either virus. Detection of RSV in the respiratory tract was 
found to be highly associated with ALRI in children whereas other viruses, such as adenovirus and 
rhinovirus, when presented alone, were less associated with ALRI and were more often detected in 
healthy children [46]. This might partly explain our findings on RSV co-infections with rhinovirus and 
with any viruses. Third, due to limited data from the literature, we were unable to conduct subgroup 
analysis by comorbidity status or by prematurity that might act as a modifier of the clinical severity. 
Fourth, for random-effect meta-analysis, estimation for between-study heterogeneity is likely to be 
biased towards zero when the number of studies is very small (e.g. three) [47]; as a result, the 
pooled estimate is more sensitive to outliers. 
Despite these limitations, our study is the first systematic review that compares the effects of RSV-
specific coinfection on the clinical severity in children <5y. Our study results suggest that RSV-hMPV 
coinfections are associated with higher risk of ICU admission and this could have relevance to the 
clinical management of paediatric patients with RSV-hMPV coinfection. No firm conclusions can be 
made regarding RSV coinfections with other viruses. Further well-designed studies are necessary to 
confirm our findings. 
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Table 1. Summary of results on the length of hospital stay (in days), grouped by co-infected virus 
Study Virus 
coinfected 
Mono-infection Co-infection Notes 
De Paulis, 2011 [22] Any viruses 8 (6–10) 8 (6–12) Median (IQR) 
Espinola, 2012 [17] Any viruses 2–12 2–15 Range 
Falkenstein-
Hagander, 2014 [40] 
Any viruses 5.0 (3.0–6.0) 3.0 (3.0–5.0) Median (IQR) 
Gagliardi, 2013 [18] Any viruses 8 8 Median 
Gokce, 2018 [25] Any viruses 7.2±3.8 7.5±4.7 Mean±SD 
Janahi, 2017 [26] Any viruses 81% 88% Proportion of ≥4 
days of stay 
Kelly, 2015 [27] Any viruses 5.1(2.1–8.0) 4.0(2.1–9.0) Median (IQR) 
Mansbach, 2012 [19] Any viruses 48% 51% Proportion of ≥3 
days of stay 
Petrarca, 2018 [32] Any viruses 5 (1–27) 5 (2–12) Median (range) 
Yu, 2010 [36] Any viruses 7.2±3.6 7.2±2.0 Mean±SD 
Aberle, 2005 [20] RV 7.6±0.3 7.4±0.4 Mean±SEM 
de Silva, 2013 [7] RV 6.1* in 0–5m 
5.9* in 6m–3y 
10.8±3.4 in 0–5m 
5.6±0.5 in 6m–3y 
Mean±SD 
Janahi, 2017 [26] RV 81% 84% Proportion of ≥4 
days of stay 
Kwon, 2019 [37] RV 5 (2–12) 4 (3–13) Median (range) 
Mansbach, 2012 [19] RV 48% 54% Proportion of ≥3 
days of stay 
Marguet, 2009 [31] RV 6 (5–8) 5 (4–6) Median (IQR) 
Petrarca, 2018 [32] RV 5 (1–27) 5 (3–9) Median (range) 
Janahi, 2017 [26] Any viruses 
minus RV 
81% 91% Proportion of ≥4 
days of stay 
Mansbach, 2012 [19] Any viruses 
minus RV 
48% 47% Proportion of ≥3 
days of stay 
Ali, 2010 [21] hMPV 4 (3–6.2) 8.5 (4–9.7) Median (IQR) 
Caracciolo, 2008 [39] hMPV 3.5±3.0 4.1±2.1 Mean±SD 
Foulongne, 2006 [23] hMPV 4 (2–5) 7 (4–8) Median (IQR) 
Aberle, 2005 [20] ADV 7.6±0.3 7.8±0.9 Mean±SEM 
*Standard deviation was not available 
 RV=rhinovirus; hMPV=human metapneumovirus; ADV=adenovirus; IQR=interquartile range; 





Figure 1. PRISMA diagram for selection of studies 
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Figure 2. Comparison of risk for use of supplement oxygen between RSV mono-infection and A) 
RSV coinfections with any viruses, B) RSV coinfections with rhinovirus, C) RSV coinfections with 






Figure 3. Comparison of risk for ICU admission between RSV mono-infection and A) RSV 
coinfections with any viruses, B) RSV coinfections with rhinovirus, C) RSV coinfections with human 




Figure 4. Comparison of risk for mechanical ventilation between RSV mono-infection and A) RSV 
coinfections with any viruses, B) RSV coinfections with rhinovirus. Mono = mono-infection; Co = co-
infection; MV = mechanical ventilation. 
